StockNews.com upgraded shares of FONAR (NASDAQ:FONR – Free Report) from a buy rating to a strong-buy rating in a research note published on Friday morning.
FONAR Trading Down 0.7 %
FONR traded down $0.10 during trading hours on Friday, hitting $15.03. 14,136 shares of the company’s stock were exchanged, compared to its average volume of 15,559. The firm has a market cap of $95.14 million, a P/E ratio of 9.82 and a beta of 1.19. FONAR has a 12-month low of $13.47 and a 12-month high of $24.05. The firm has a 50 day moving average of $16.11 and a 200 day moving average of $16.33.
FONAR (NASDAQ:FONR – Get Free Report) last issued its earnings results on Friday, September 27th. The medical equipment provider reported $0.13 earnings per share for the quarter. The firm had revenue of $25.94 million for the quarter. FONAR had a net margin of 10.27% and a return on equity of 6.77%.
Institutional Investors Weigh In On FONAR
About FONAR
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
Featured Articles
- Five stocks we like better than FONAR
- How to Use the MarketBeat Excel Dividend Calculator
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- Dividend Capture Strategy: What You Need to Know
- MarketBeat Week in Review – 11/4 – 11/8
- Want to Profit on the Downtrend? Downtrends, Explained.
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for FONAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FONAR and related companies with MarketBeat.com's FREE daily email newsletter.